XML 40 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Quarterly Financial Data
12 Months Ended
Mar. 31, 2012
Quarterly Financial Data
14.   Quarterly Financial Data

The table below lists financial information (unaudited) by quarter for each of the two fiscal years ended March 31, 2012 and 2011.

2012
 
First
   
Second
   
Third
   
Fourth
   
Total Year
 
Net Sales
  $ 8,120,000     $ 8,352,000     $ 6,518,000     $ 6,505,000     $ 29,495,000  
Cost of Products Sold
    4,742,000       4,785,000       3,828,000       4,282,000       17,637,000  
Gross Profit
    3,378,000       3,567,000       2,690,000       2,223,000       11,858,000  
Research & Development Expenses
    1,692,000       1,714,000       1,660,000       1,475,000       6,541,000  
Selling, General & Administrative Expenses
    2,116,000       2,207,000       1,890,000       1,768,000       7,981,000  
Net Income (Loss)
  $ 18,000     $ (254,000 )   $ (812,000 )   $ (1,064,000 )   $ (2,112,000 )
Basic and diluted Income (Loss) per Common Share
  $ 0.00     $ (0.01 )   $ (0.03 )   $ (0.03 )   $ (0.07 )
Weighted Average Common Shares Outstanding
    30,687,000       30,827,000       30,972,000       31,006,000       30,873,000  
                                         
2011
 
First
   
Second
   
Third
   
Fourth
   
Total Year
 
Net Sales
  $ 6,253,000     $ 6,999,000     $ 7,720,000     $ 7,866,000     $ 28,838,000  
Cost of Products Sold
    3,335,000       4,097,000       4,636,000       4,411,000       16,479,000  
Gross Profit
    2,918,000       2,902,000       3,084,000       3,455,000       12,359,000  
Research & Development Expenses
    1,288,000       1,303,000       1,362,000       1,678,000       5,631,000  
Selling, General & Administrative Expenses
    1,891,000       1,784,000       1,892,000       1,986,000       7,553,000  
Net Loss
  $ (273,000 )   $ (398,000 )   $ (649,000 )   $ (562,000 )   $ (1,882,000 )
Basic and diluted Loss per Common Share
  $ (0.01 )   $ (0.02 )   $ (0.03 )   $ (0.02 )   $ (0.07 )
Weighted Average Common Shares Outstanding
    24,675,000       25,659,000       25,908,000       29,285,000       26,366,000